EGFR and non-small cell lung carcinoma: EGFR::SEPTIN14 (NSCLC P22152) has been described in a NSCLC patient responding to icotinib as well as an acquired osimertinib resistance mutation in a patient with EGFR exon 19 deletion [27, 28].